Живи долго! Научный подход к долгой молодости и здоровью

1379

An JY, Kerns KA, Ouellette A, et al. Rapamycin rejuvenates oral health in aging mice. Elife. 2020;9:e54318. https://pubmed.ncbi.nlm.nih.gov/32342860/

1380

Altschuler RA, Kanicki A, Martin C, Kohrman DC, Miller RA. Rapamycin but not acarbose decreases age-related loss of outer hair cells in the mouse cochlea. Hear Res. 2018;370:11–5. https://pubmed.ncbi.nlm.nih.gov/30245283/

1381

Lesniewski LA, Seals DR, Walker AE, et al. Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways. Aging Cell. 2017;16(1):17–26. https://pubmed.ncbi.nlm.nih.gov/27660040/

1382

Zaseck LW, Miller RA, Brooks SV. Rapamycin attenuates age-associated changes in tibialis anterior tendon viscoelastic properties. J Gerontol A Biol Sci Med Sci. 2016;71(7):858–65. https://pubmed.ncbi.nlm.nih.gov/26809496/

1383

Dai DF, Karunadharma PP, Chiao YA, et al. Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell. 2014;13(3):529–39. https://pubmed.ncbi.nlm.nih.gov/24612461/

1384

Arriola Apelo SI, Pumper CP, Baar EL, Cummings NE, Lamming DW. Intermittent administration of rapamycin extends the life span of female C57BL/6J mice. J Gerontol A Biol Sci Med Sci. 2016;71(7):876–81. https://pubmed.ncbi.nlm.nih.gov/27091134/

1385

Bitto A, Ito TK, Pineda VV, et al. Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. Elife. 2016;5:e16351. https://pubmed.ncbi.nlm.nih.gov/27549339/

1386

Urfer SR, Kaeberlein TL, Mailheau S, et al. A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs. Geroscience. 2017;39(2):117–27. https://pubmed.ncbi.nlm.nih.gov/28374166/

1387

González A, Hall MN, Lin SC, Hardie DG. AMPK and TOR: the Yin and Yang of cellular nutrient sensing and growth control. Cell Metab. 2020;31(3):472–92. https://pubmed.ncbi.nlm.nih.gov/32130880/

1388

Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183–203. https://pubmed.ncbi.nlm.nih.gov/31937935/

1389

Michels KB, Ekbom A. Caloric restriction and incidence of breast cancer. JAMA. 2004;291(10):1226–30. https://pubmed.ncbi.nlm.nih.gov/15010444/

1390

Wazir U, Newbold RF, Jiang WG, Sharma AK, Mokbel K. Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer. Oncol Rep. 2013;29(5):1969–74. https://pubmed.ncbi.nlm.nih.gov/23503572/

1391

Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011;68(7):724–31. https://pubmed.ncbi.nlm.nih.gov/21727255/

1392

Dar BA, Dar MA, Bashir S. Calorie restriction the fountain of youth. Food Nutr Sci. 2012;3(11):1522–6. https://www.scirp.org/journal/paperinformation.aspx?paperid=24485

1393

Dirks AJ, Leeuwenburgh C. Caloric restriction in humans: potential pitfalls and health concerns. Mech Ageing Dev. 2006;127(1):1–7. https://pubmed.ncbi.nlm.nih.gov/16226298/

1394

Bourzac K. Interventions: live long and prosper. Nature. 2012;492(7427):S18–20. https://pubmed.ncbi.nlm.nih.gov/23222670/

1395

Nakagawa S, Lagisz M, Hector KL, Spencer HG. Comparative and meta-analytic insights into life extension via dietary restriction. Aging Cell. 2012;11(3):401–9. https://pubmed.ncbi.nlm.nih.gov/22268691/

1396

Solon-Biet SM, McMahon AC, Ballard JWO, et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 2014;19(3):418–30. https://pubmed.ncbi.nlm.nih.gov/24606899/

1397

Ross MH. Length of life and nutrition in the rat. J Nutr. 1961;75:197–210. https://pubmed.ncbi.nlm.nih.gov/14494200/

1398

Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183–203. https://pubmed.ncbi.nlm.nih.gov/31937935/

1399

Fontana L, Partridge L, Longo VD. Extending healthy life span – from yeast to humans. Science. 2010;328(5976):321–6. https://pubmed.ncbi.nlm.nih.gov/20395504/

1400

Kitada M, Xu J, Ogura Y, Monno I, Koya D. Mechanism of activation of mechanistic target of rapamycin complex 1 by methionine. Front Cell Dev Biol. 2020;8:715. https://pubmed.ncbi.nlm.nih.gov/32850834/

1401

Dumas SN, Lamming DW. Next generation strategies for geroprotection via mTORC1 inhibition. J Gerontol A Biol Sci Med Sci. 2020;75(1):14–23. https://pubmed.ncbi.nlm.nih.gov/30794726/

1402

Norton LE, Layman DK, Bunpo P, Anthony TG, Brana DV, Garlick PJ. The leucine content of a complete meal directs peak activation but not duration of skeletal muscle protein synthesis and mammalian target of rapamycin signaling in rats. J Nutr. 2009;139(6):1103–9. https://pubmed.ncbi.nlm.nih.gov/19403715/

1403

Schmidt JA, Rinaldi S, Scalbert A, et al. Plasma concentrations and intakes of amino acids in male meat-eaters, fish-eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort. Eur J Clin Nutr. 2016;70(3):306–12. https://pubmed.ncbi.nlm.nih.gov/26395436/

1404

Jafari S, Hezaveh E, Jalilpiran Y, et al. Plant-based diets and risk of disease mortality: a systematic review and meta-analysis of cohort studies. Crit Rev Food Sci Nutr. Published online May 6, 2021:1–13. Accessed June 23, 2021.; https://pubmed.ncbi.nlm.nih.gov/33951994/

1405

Tantamango-Bartley Y, Jaceldo-Siegl K, Fan J, Fraser G. Vegetarian diets and the incidence of cancer in a low-risk population. Cancer Epidemiol Biomarkers Prev. 2013;22(2):286–94. https://pubmed.ncbi.nlm.nih.gov/23169929/

1406

Green CL, Lamming DW. Regulation of metabolic health by essential dietary amino acids. Mech Ageing Dev. 2019;177:186–200. https://pubmed.ncbi.nlm.nih.gov/30044947/

1407

Schmidt JA, Rinaldi S, Scalbert A, et al. Plasma concentrations and intakes of amino acids in male meat-eaters, fish-eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort. Eur J Clin Nutr. 2016;70(3):306–12. https://pubmed.ncbi.nlm.nih.gov/26395436/

1408

Willcox BJ, Willcox DC, Todoriki H, et al. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world’s longest-lived people and its potential impact on morbidity and life span. Ann N Y Acad Sci. 2007;1114:434–55. https://pubmed.ncbi.nlm.nih.gov/17986602/

1409

Davinelli S, Willcox DC, Scapagnini G. Extending healthy ageing: nutrient sensitive pathway and centenarian population. Immun Ageing. 2012;9:9. https://pubmed.ncbi.nlm.nih.gov/22524452/

1410

Fraser GE, Shavlik DJ. Ten years of life: is it a matter of choice? Arch Intern Med. 2001;161(13):1645–52. https://pubmed.ncbi.nlm.nih.gov/11434797/

1411

Yasuda M, Tanaka Y, Kume S, et al. Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes. Biochim Biophys Acta. 2014;1842(7):1097–108. https://pubmed.ncbi.nlm.nih.gov/24726883/

1412

Obersby D, Chappell DC, Dunnett A, Tsiami AA. Plasma total homocysteine status of vegetarians compared with omnivores: a systematic review and meta-analysis. Br J Nutr. 2013;109(5):785–94. https://pubmed.ncbi.nlm.nih.gov/23298782/

1413

Khayati K, Antikainen H, Bonder EM, et al. The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice. FASEB J. 2017;31(2):598–609. https://pubmed.ncbi.nlm.nih.gov/28148781/

1414

Dumas SN, Lamming DW. Next generation strategies for geroprotection via mTORC1 inhibition. J Gerontol A Biol Sci Med Sci. 2020;75(1):14–23. https://pubmed.ncbi.nlm.nih.gov/30794726/

1415

Melnik BC. Dietary intervention in acne: attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinol. 2012;4(1):20–32. https://pubmed.ncbi.nlm.nih.gov/22870349/

1416

Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Clin Cosmet Investig Dermatol. 2015;8:371–88. https://pubmed.ncbi.nlm.nih.gov/26203267/

1417

Moro T, Brightwell CR, Velarde B, et al. Whey protein hydrolysate increases amino acid uptake, mTORC1 signaling, and protein synthesis in skeletal muscle of healthy young men in a randomized crossover trial. J Nutr. 2019;149(7):1149–58. https://pubmed.ncbi.nlm.nih.gov/31095313/

1418

Melnik BC. Milk – a nutrient system of mammalian evolution promoting mTORC1-dependent translation. Int J Mol Sci. 2015;16(8):17048–87. https://pubmed.ncbi.nlm.nih.gov/26225961/

1419

Melnik BC, John SM, Carrera-Bastos P, Cordain L. The impact of cow’s milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer. Nutr Metab (Lond). 2012;9(1):74. https://pubmed.ncbi.nlm.nih.gov/22891897/

1420

Melnik BC. Milk – a nutrient system of mammalian evolution promoting mTORC1-dependent translation. Int J Mol Sci. 2015;16(8):17048–87. https://pubmed.ncbi.nlm.nih.gov/26225961/

1421

Melnik BC. Lifetime impact of cow’s milk on overactivation of mTORC1: from fetal to childhood overgrowth, acne, diabetes, cancers, and neurodegeneration. Biomolecules. 2021;11(3):404. https://pubmed.ncbi.nlm.nih.gov/33803410/

1422

Melnik BC, John SM, Schmitz G. Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth. Nutr J. 2013;12:103. https://pubmed.ncbi.nlm.nih.gov/23883112/

1423

Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol. 2002;138(12):1584–90. https://pubmed.ncbi.nlm.nih.gov/12472346/

1424

Danby FW. Acne and milk, the diet myth, and beyond. J Am Acad Dermatol. 2005;52(2):360–2. https://pubmed.ncbi.nlm.nih.gov/15692488/

1425

Aghasi M, Golzarand M, Shab-Bidar S, Aminianfar A, Omidian M, Taheri F. Dairy intake and acne development: a meta-analysis of observational studies. Clin Nutr. 2019;38(3):1067–75. https://pubmed.ncbi.nlm.nih.gov/29778512/

1426

Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Clin Cosmet Investig Dermatol. 2015;8:371–88. https://pubmed.ncbi.nlm.nih.gov/26203267/

1427

Melnik BC. Lifetime impact of cow’s milk on overactivation of mTORC1: from fetal to childhood overgrowth, acne, diabetes, cancers, and neurodegeneration. Biomolecules. 2021;11(3):404. https://pubmed.ncbi.nlm.nih.gov/33803410/

1428

Melnik BC. Dietary intervention in acne: attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinol. 2012;4(1):20–32. https://pubmed.ncbi.nlm.nih.gov/22870349/

1429

Baron JA, Weiderpass E, Newcomb PA, et al. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control. 2001;12(10):875–80. https://pubmed.ncbi.nlm.nih.gov/11808705/

1430

Sutcliffe S, Giovannucci E, Isaacs WB, Willett WC, Platz EA. Acne and risk of prostate cancer. Int J Cancer. 2007;121(12):2688–92. https://pubmed.ncbi.nlm.nih.gov/17724724/

1431

Melnik BC, John SM, Carrera-Bastos P, Cordain L. The impact of cow’s milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer. Nutr Metab (Lond). 2012;9(1):74. https://pubmed.ncbi.nlm.nih.gov/22891897/

1432

Sargsyan A, Dubasi HB. Milk consumption and prostate cancer: a systematic review. World J Mens Health. 2021;39(3):419–28. https://pubmed.ncbi.nlm.nih.gov/32777868/

1433

Pettersson A, Kasperzyk JL, Kenfield SA, et al. Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomarkers Prev. 2012;21(3):428–36. https://pubmed.ncbi.nlm.nih.gov/22315365/

1434

Tognon G, Nilsson LM, Shungin D, et al. Nonfermented milk and other dairy products: associations with all-cause mortality. Am J Clin Nutr. 2017;105(6):1502–11. https://pubmed.ncbi.nlm.nih.gov/28490510/

1435

Melnik BC, Schmitz G. Pasteurized non-fermented cow’s milk but not fermented milk is a promoter of mTORC1-driven aging and increased mortality. Ageing Res Rev. 2021;67:101270. https://pubmed.ncbi.nlm.nih.gov/33571703/

1436

Gao X, Jia H, Chen G, Li C, Hao M. Yogurt intake reduces all-cause and cardiovascular disease mortality: a meta-analysis of eight prospective cohort studies. Chin J Integr Med. 2020;26(6):462–8. https://pubmed.ncbi.nlm.nih.gov/31970674/

1437

Sahin K, Orhan C, Tuzcu M, et al. Tomato powder modulates NF-¿B, mTOR, and Nrf2 pathways during aging in healthy rats. J Aging Res. 2019;2019:1643243. https://pubmed.ncbi.nlm.nih.gov/30719353/

1438

Takeshima M, Ono M, Higuchi T, Chen C, Hara T, Nakano S. Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines. Cancer Sci. 2014;105(3):252–7. https://pubmed.ncbi.nlm.nih.gov/24397737/

1439

Thomson CA, Ho E, Strom MB. Chemopreventive properties of 3,3’-diindolylmethane in breast cancer: evidence from experimental and human studies. Nutr Rev. 2016;74(7):432–43. https://pubmed.ncbi.nlm.nih.gov/27261275/

1440

Du H, Zhang X, Zeng Y, et al. A novel phytochemical, DIM, inhibits proliferation, migration, invasion and TNF-a induced inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients by targeting MAPK and AKT/mTOR signal pathway. Front Immunol. 2019;10:1620. https://pubmed.ncbi.nlm.nih.gov/31396207/

1441

Zhang Y, Gilmour A, Ahn YH, de la Vega L, Dinkova-Kostova AT. The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. Phytomedicine. 2021;86:153062. https://pubmed.ncbi.nlm.nih.gov/31409554/

1442

Li N, Wu X, Zhuang W, et al. Green leafy vegetable and lutein intake and multiple health outcomes. Food Chem. 2021;360:130145. https://pubmed.ncbi.nlm.nih.gov/34034049/

1443

Sato A. mTOR, a potential target to treat autism spectrum disorder. CNS Neurol Disord Drug Targets. 2016;15(5):533–43. https://pubmed.ncbi.nlm.nih.gov/27071790/

1444

Matusheski NV, Juvik JA, Jeffery EH. Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. Phytochemistry. 2004;65(9):1273–81. https://pubmed.ncbi.nlm.nih.gov/15184012/

1445

Singh K, Connors SL, Macklin EA, et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. 2014;111(43):15550–5. https://pubmed.ncbi.nlm.nih.gov/25313065/

1446

Wanke V, Cameroni E, Uotila A, et al. Caffeine extends yeast lifespan by targeting TORC1. Mol Microbiol. 2008;69(1):277–85. https://pubmed.ncbi.nlm.nih.gov/18513215/

1447

Takahashi K, Yanai S, Shimokado K, Ishigami A. Coffee consumption in aged mice increases energy production and decreases hepatic mTOR levels. Nutrition. 2017;38:1–8. https://pubmed.ncbi.nlm.nih.gov/28526373/

1448

Van Aller GS, Carson JD, Tang W, et al. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem Biophys Res Commun. 2011;406(2):194–9. https://pubmed.ncbi.nlm.nih.gov/21300025/

1449

Elsaie ML, Abdelhamid MF, Elsaaiee LT, Emam HM. The efficacy of topical 2 % green tea lotion in mild-to-moderate acne vulgaris. J Drugs Dermatol. 2009;8(4):358–64. https://pubmed.ncbi.nlm.nih.gov/19363854/

1450

Cassidy A, Chung M, Zhao N, et al. Dose – response relation between tea consumption and risk of cardiovascular disease and all-cause mortality: a systematic review and meta-analysis of population-based studies. Adv Nutr. 2020;11(4):790–814. https://pubmed.ncbi.nlm.nih.gov/32073596/

1451

Lamming DW. Inhibition of the mechanistic target of rapamycin (mTOR) – rapamycin and beyond. Cold Spring Harb Perspect Med. 2016;6(5). https://pubmed.ncbi.nlm.nih.gov/27048303/

1452

Kennedy BK, Lamming DW. The mechanistic target of rapamycin: the grand conducTOR of metabolism and aging. Cell Metab. 2016;23(6):990–1003. https://pubmed.ncbi.nlm.nih.gov/27304501/

1453

Morley JE. The mTOR conundrum: essential for muscle function, but dangerous for survival. J Am Med Dir Assoc. 2016;17(11):963–6. https://pubmed.ncbi.nlm.nih.gov/27780571/

1454

Blagosklonny MV. Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives. Aging (Albany NY). 2010;2(5):265–73. https://pubmed.ncbi.nlm.nih.gov/20519781/

1455

Markofski MM, Dickinson JM, Drummond MJ, et al. Effect of age on basal muscle protein synthesis and mTORC1 signaling in a large cohort of young and older men and women. Exp Gerontol. 2015;65:1–7. https://pubmed.ncbi.nlm.nih.gov/25735236/

1456

Leenders M, Verdijk LB, van der Hoeven L, et al. Prolonged leucine supplementation does not augment muscle mass or affect glycemic control in elderly type 2 diabetic men. J Nutr. 2011;141(6):1070–6. https://pubmed.ncbi.nlm.nih.gov/21525248/

1457

Verhoeven S, Vanschoonbeek K, Verdijk LB, et al. Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men. Am J Clin Nutr. 2009;89(5):1468–75. https://pubmed.ncbi.nlm.nih.gov/19321567/

1458

Tang H, Shrager JB, Goldman D. Rapamycin protects aging muscle. Aging (Albany NY). 2019;11(16):5868–70. https://pubmed.ncbi.nlm.nih.gov/31454792/

1459

Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183–203. https://pubmed.ncbi.nlm.nih.gov/31937935/

1460

Kennedy BK, Lamming DW. The mechanistic target of rapamycin: the grand conducTOR of metabolism and aging. Cell Metab. 2016;23(6):990–1003. https://pubmed.ncbi.nlm.nih.gov/27304501/

1461

Тор (Tor) – в германо-скандинавской мифологии бог грома и молний, защищающий богов и людей от великанов и чудовищ с помощью боевого молота (hammer). – Примеч. ред.

1462

Lamming DW, Salmon AB. TORwards a victory over aging. J Gerontol A Biol Sci Med Sci. 2020;75(1):1–3. https://pubmed.ncbi.nlm.nih.gov/31544928/

1463

Caldana C, Martins MCM, Mubeen U, Urrea-Castellanos R. The magic “hammer” of TOR: the multiple faces of a single pathway in the metabolic regulation of plant growth and development. J Exp Bot. 2019;70(8):2217–25. https://pubmed.ncbi.nlm.nih.gov/30722050/

1464

Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183–203. https://pubmed.ncbi.nlm.nih.gov/31937935/

1465

Kaeberlein M, Galvan V. Rapamycin and Alzheimer’s disease: time for a clinical trial? Sci Transl Med. 2019;11(476):eaar4289. https://pubmed.ncbi.nlm.nih.gov/30674654/

1466

Kapahi P, Chen D, Rogers AN, et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab. 2010;11(6):453–65. https://pubmed.ncbi.nlm.nih.gov/20519118/

1467

Sansevero TB. The Profit Machine. Cultiva Libros; 2009.

1468

Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc. 1972;20(4):145–7. https://pubmed.ncbi.nlm.nih.gov/5016631/

1469

Talaulikar VS, Manyonda IT. Vitamin C as an antioxidant supplement in women’s health: a myth in need of urgent burial. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):10–3. https://pubmed.ncbi.nlm.nih.gov/21507551/

1470

Liebman SE, Le TH. Eat your broccoli: oxidative stress, NRF2, and sulforaphane in chronic kidney disease. Nutrients. 2021;13(1):266. https://pubmed.ncbi.nlm.nih.gov/33477669/

1471

Peng C, Wang X, Chen J, et al. Biology of ageing and role of dietary antioxidants. Biomed Res Int. 2014;2014:831841. https://pubmed.ncbi.nlm.nih.gov/24804252/

1472

Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):676–92. https://pubmed.ncbi.nlm.nih.gov/20471444/

1473

Peng C, Wang X, Chen J, et al. Biology of ageing and role of dietary antioxidants. Biomed Res Int. 2014;2014:831841. https://pubmed.ncbi.nlm.nih.gov/24804252/

1474

Rinnerthaler M, Bischof J, Streubel MK, Trost A, Richter K. Oxidative stress in aging human skin. Biomolecules. 2015;5(2):545–89. https://pubmed.ncbi.nlm.nih.gov/25906193/

1475

Logan S, Royce GH, Owen D, et al. Accelerated decline in cognition in a mouse model of increased oxidative stress. GeroScience. 2019;41(5):591–607. https://pubmed.ncbi.nlm.nih.gov/31641924/

1476

Hensley K, Floyd RA. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys. 2002;397(2):377–83. https://pubmed.ncbi.nlm.nih.gov/11795897/

1477

Yeung AWK, Tzvetkov NT, El-Tawil OS, Bungau SG, Abdel-Daim MM, Atanasov AG. Antioxidants: scientific literature landscape analysis. Oxid Med Cell Longev. 2019;2019:8278454. https://pubmed.ncbi.nlm.nih.gov/30728893/

1478

Bast A, Haenen GRMM. Ten misconceptions about antioxidants. Trends Pharmacol Sci. 2013;34(8):430–6. https://pubmed.ncbi.nlm.nih.gov/23806765/

1479

Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev. 1990;65(3):375–98. https://pubmed.ncbi.nlm.nih.gov/2205304/

1480

Fusco D, Colloca G, Lo Monaco MR, Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interv Aging. 2007;2(3):377–87. https://pubmed.ncbi.nlm.nih.gov/18044188/